Prostaglandin E 2 – EP4 Signaling at the Gut–Immune–Metabolic Interface: A Lipid Mediator Perspective on Obesity and Insulin Resistance
Comprehensive Physiology · 2026
DOI: 10.1002/cph4.70099 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Comprehensive Physiology, 2026. Verfasst von Nila Ganamurali und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaco-Netinformatics Research Lab, Department of Psychiatry, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sc…. Hauptthemen laut MEDLINE: Insulin Resistance, Dinoprostone, Obesity, Receptors, Prostaglandin E, EP4 Subtype. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 33 Literaturangaben.
Abstract (Originalsprache)
Despite advances in dietary and pharmacologic therapies, obesity rates continue to escalate globally. Emerging evidence implicates the gut–immune interface as a key determinant of metabolic dysfunction. This review highlights the prostaglandin E 2 (PGE 2 ) EP4 signaling axis as a pivotal mediator linking gut dysbiosis to systemic insulin resistance. In obesity, elevated COX‐2‐derived PGE 2 reprograms the gut microbiota, depleting short‐chain fatty acid (SCFA)‐producing taxa and reducing regulatory T cell (Treg) homeostasis. The ensuing loss of intestinal integrity promotes metabolic endotoxemia and chronic low‐grade inflammation, culminating in insulin resistance. Targeting the PGE 2 –EP4 microbiota Treg network through EP4 antagonists or microbiome restoration offers a promising therapeutic strategy to restore metabolic balance and prevent obesity associated complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaco-Netinformatics Research Lab, Department of Psychiatry, Saveetha Medical College and Hospital, Saveetha Institute of Medical and Technical Sciences (SIMATS), Saveetha University, Chennai, Tamil Nadu, India.
ORCID-Profile: Nila Ganamurali, Sarvesh Sabarathinam
Zitieren
APA
Ganamurali, N., & Sabarathinam, S. (2026). Prostaglandin E 2 – EP4 Signaling at the Gut–Immune–Metabolic Interface: A Lipid Mediator Perspective on Obesity and Insulin Resistance. Comprehensive Physiology. https://doi.org/10.1002/cph4.70099
Vancouver
Ganamurali N, Sabarathinam S. Prostaglandin E 2 – EP4 Signaling at the Gut–Immune–Metabolic Interface: A Lipid Mediator Perspective on Obesity and Insulin Resistance. Comprehensive Physiology. 2026. doi:10.1002/cph4.70099
BibTeX
@article{Ganamurali2026,
author = {Ganamurali, Nila and Sabarathinam, Sarvesh},
title = {Prostaglandin E 2 – EP4 Signaling at the Gut–Immune–Metabolic Interface: A Lipid Mediator Perspective on Obesity and Insulin Resistance},
journal = {Comprehensive Physiology},
year = {2026},
doi = {10.1002/cph4.70099}
}
EUVIMED